211 related articles for article (PubMed ID: 15021220)
1. Factors for progression and glaucoma treatment: the Early Manifest Glaucoma Trial.
Leske MC; Heijl A; Hyman L; Bengtsson B; Komaroff E
Curr Opin Ophthalmol; 2004 Apr; 15(2):102-6. PubMed ID: 15021220
[TBL] [Abstract][Full Text] [Related]
2. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial.
Leske MC; Heijl A; Hussein M; Bengtsson B; Hyman L; Komaroff E;
Arch Ophthalmol; 2003 Jan; 121(1):48-56. PubMed ID: 12523884
[TBL] [Abstract][Full Text] [Related]
3. Predictors of long-term progression in the early manifest glaucoma trial.
Leske MC; Heijl A; Hyman L; Bengtsson B; Dong L; Yang Z;
Ophthalmology; 2007 Nov; 114(11):1965-72. PubMed ID: 17628686
[TBL] [Abstract][Full Text] [Related]
4. [Early Manifest Glaucoma Trial update 2004].
Erb C
Ophthalmologe; 2005 Mar; 102(3):219-21. PubMed ID: 15700191
[TBL] [Abstract][Full Text] [Related]
5. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial.
Bengtsson B; Leske MC; Hyman L; Heijl A;
Ophthalmology; 2007 Feb; 114(2):205-9. PubMed ID: 17097736
[TBL] [Abstract][Full Text] [Related]
6. Early Manifest Glaucoma Trial: design and baseline data.
Leske MC; Heijl A; Hyman L; Bengtsson B
Ophthalmology; 1999 Nov; 106(11):2144-53. PubMed ID: 10571351
[TBL] [Abstract][Full Text] [Related]
7. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.
Heijl A; Leske MC; Bengtsson B; Hyman L; Bengtsson B; Hussein M;
Arch Ophthalmol; 2002 Oct; 120(10):1268-79. PubMed ID: 12365904
[TBL] [Abstract][Full Text] [Related]
8. Intraocular pressure reduction with a fixed treatment protocol in the Early Manifest Glaucoma Trial.
Heijl A; Leske MC; Hyman L; Yang Z; Bengtsson B;
Acta Ophthalmol; 2011 Dec; 89(8):749-54. PubMed ID: 20236252
[TBL] [Abstract][Full Text] [Related]
9. Disc hemorrhages and treatment in the early manifest glaucoma trial.
Bengtsson B; Leske MC; Yang Z; Heijl A;
Ophthalmology; 2008 Nov; 115(11):2044-8. PubMed ID: 18692244
[TBL] [Abstract][Full Text] [Related]
10. Treatment and vision-related quality of life in the early manifest glaucoma trial.
Hyman LG; Komaroff E; Heijl A; Bengtsson B; Leske MC;
Ophthalmology; 2005 Sep; 112(9):1505-13. PubMed ID: 16019074
[TBL] [Abstract][Full Text] [Related]
11. Measuring visual field progression in the Early Manifest Glaucoma Trial.
Heijl A; Leske MC; Bengtsson B; Bengtsson B; Hussein M;
Acta Ophthalmol Scand; 2003 Jun; 81(3):286-93. PubMed ID: 12780410
[TBL] [Abstract][Full Text] [Related]
12. Effects of argon laser trabeculoplasty in the Early Manifest Glaucoma Trial.
Heijl A; Peters D; Leske MC; Bengtsson B
Am J Ophthalmol; 2011 Nov; 152(5):842-8. PubMed ID: 21843876
[TBL] [Abstract][Full Text] [Related]
13. Effect of treatment by medicine or surgery on intraocular pressure and pulsatile ocular blood flow in normal-pressure glaucoma.
Poinoosawmy D; Indar A; Bunce C; Garway-Heath DF; Hitchings RA
Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):721-6. PubMed ID: 12271368
[TBL] [Abstract][Full Text] [Related]
14. Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment Study.
Lindén C; Heijl A; Jóhannesson G; Aspberg J; Andersson Geimer S; Bengtsson B
Acta Ophthalmol; 2018 Sep; 96(6):567-572. PubMed ID: 30242986
[TBL] [Abstract][Full Text] [Related]
15. Selective laser trabeculoplasty as replacement therapy in medically controlled glaucoma patients.
De Keyser M; De Belder M; De Belder J; De Groot V
Acta Ophthalmol; 2018 Aug; 96(5):e577-e581. PubMed ID: 28636188
[TBL] [Abstract][Full Text] [Related]
16. The Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline data.
Bengtsson B; Heijl A; Johannesson G; Andersson-Geimer S; Aspberg J; Lindén C
Acta Ophthalmol; 2018 Sep; 96(6):557-566. PubMed ID: 30171664
[TBL] [Abstract][Full Text] [Related]
17. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
Nordmann JP; Mertz B; Yannoulis NC; Schwenninger C; Kapik B; Shams N;
Am J Ophthalmol; 2002 Jan; 133(1):1-10. PubMed ID: 11755834
[TBL] [Abstract][Full Text] [Related]
18. [Selective laser trabeculoplasty: Effect of number of preoperative topical glaucoma medications on pressure lowering and success rate].
Bonnel S; Fenolland JR; Marill AF; Gaillard R; Rosenberg R; Theillac V; Mazharian A; Giraud JM; Renard JP
J Fr Ophtalmol; 2017 Jan; 40(1):22-28. PubMed ID: 28081918
[TBL] [Abstract][Full Text] [Related]
19. Intraocular pressure-lowering medications and long-term outcomes of selective laser trabeculoplasty.
Woo DM; Healey PR; Graham SL; Goldberg I
Clin Exp Ophthalmol; 2015; 43(4):320-7. PubMed ID: 25287743
[TBL] [Abstract][Full Text] [Related]
20. A randomized clinical trial of selective laser trabeculoplasty versus argon laser trabeculoplasty in patients with pseudoexfoliation.
Kent SS; Hutnik CM; Birt CM; Damji KF; Harasymowycz P; Si F; Hodge W; Pan I; Crichton A
J Glaucoma; 2015; 24(5):344-7. PubMed ID: 23835670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
